13 Dividend Growth Stocks With A Strong Buy Rating

Companies that have raised their dividend payments for at least 10 consecutive years are known as dividend achievers. It's an exclusive club containing just 335 companies.

It's always hard to find the good stocks from the bad performer. I personal approach is based on fundamentals. If a stock looks cheap, it offers values, than it might be buy. But sometimes they are cheap for a simple reason. They have longer enduring operational problems or face a hard headwind for the future.

It could also make sense to look what analysts recommend or discover the trade statistics of big guru's like Warren Buffett or George Soros.

Today I like to focus on the highest recommended stocks from the dividend achievers list. Those stocks are highlights and were rewarded by analysts with the highest buy recommendation, a strong buy.

Only 13 of 335 companies received such a high rating. Attached you can find a full list of the results.

These are the results....

17 Best Healthcare Dividend Growth Picks Of The Past 20 Years

The healthcare sector should be an important part of every dividend investor's portfolio. Healthcare spending as a portion of GDP in OECD countries is expected to rise steadily over the coming decades. In East Asia, healthcare spending will also rise relative to GDP, given the steep drop in fertility in that region over the last 20 years.

An aging population is a very long-lived, secular trend, and so many well-positioned healthcare businesses have steady growth prospects as far out as the eye can see. Luckily for income investors, the healthcare sector includes many businesses that are stable, dividend-minded and have good balance sheets.

Today, I like to introduce a few of the best dividend growth stocks from the healthcare sector. You might have some great names in your mind, like Johnson & Johnson or Medtronic.

For me, the medical equipment industry is a great way to invest into the future. Pharmacy is also a great but they are more cyclic and threaten by biotech. Those get also pressure from bio-similars.

There is no guarantee for a good return in the future but I feel confident to own some of the best names in the sector.

These are the best Healthcare dividend growth picks of the past 20 years. Which stocks do you like?

8 Small Cap Dividend Growth Stocks Warren Buffett Would Love

Today I'd like to share small-capstocks with businesses that are both understandable and durable, but trade at prices I personally deem too high. All businesses have traits Buffett would love: durable brands, strong competitive positions, and low-cost advantages. If Mr. Market gives me a deal, I'll be buying shares of each with both hands.

The fascinating thing about low market valuations is that the company can grow at a faster pace because their current market potential seems to be enormous.

The bad thing about those stocks is that they offer a higher risk. However, let's try the screen and face the facts.

Here are the results:

11 Dividend Achievers With Strong Buy Rating

Are you looking for stocks that are worth to buy? Sure, we all do! Today I like to show you some of the stocks with the highest buy rating within the Dividend Growth space.

I've compiled all Dividend Achievers, stocks that have raised dividends over a period of at least 10 years without a break, and selected them by the highest analyst rating.

Currently, 167 companies (nearly half of the results) have a buy or better rating. Finally, eleven stocks got a strong buy rating. These are my 4 favorite results:

9 Dividend Achievers With A Strong Buy Rating

Analysts often have a good sense about the development of stocks due to their intensive research related to the company.

Not all analysts predict the correct economic development but they do a very good basic desk research and they have conversations with the management teams of the company, so not many people a as good informed as analysts.

Today I've listed all stocks with more than 10 years of consecutive dividend growth (Dividend Achievers) and a strong buy rating. Only nine companies have received the highest buy rating by analysts. Six of them are listed on the technology stock exchange NASDAQ.

Only four firms have a market capitalization over one billion US-Dollar. Keep in mind that those stocks also contain a higher risk for invvestors.

The only 9 Dividend Achievers with a strong buy rating are....

12 Healthcare Dividend Stocks With High Potential To Boost Growth And Hike Dividends

Healthcare dividend stocks with low payout ratios and small debt figures originally published at long-term-investments.blogspot.com. I love the combination of low debt with little payout ratios. 

The debt situation is one of the most important issues in corporate finance. It also expresses the ability to grow sales and earnings by enlarging the balance sheet with bank loans.

Only a low leveraged corporate has potential to boost sales without taking new investors into the boat that dilute the current earnings per share.

Today I would like to start an article serial about low leveraged stocks from several sectors with currently small dividend payouts. I believe it’s good to see what companies have the biggest potential to give shareholders huge amounts of money back in the near future and believe me, the tech sector is not the only place to be.

My criteria are a low dividend payout ratio of less than 20 percent as well as a debt-to-equity ratio under 0.5. Only twelve stocks fulfilled these very tight defined criteria.

One result is a High-Yield and nine stocks are recommended to buy or better. Most of the results come from the medical appliances & supplies or equipment industry.

Ex-Dividend Stocks: Best Dividend Paying Shares On February 25, 2013

The best yielding and biggest ex-dividend stocks researched by ”long-term-investments.blogspot.com”. Dividend Investors should have a quiet overview of stocks with upcoming ex dividend dates.

The ex dividend date is the final date on which the new stock buyer couldn’t receive the next dividend. If you like to receive the dividend, you need to buy the stock before the ex dividend date. I made a little screen of the best yielding stocks with a higher capitalization that have their ex date on the next trading day.

A full list of all stocks with payment dates can be found here: Ex-Dividend Stocks February 25, 2013. In total, 12 stocks and preferred shares go ex dividend - of which 6 yield more than 3 percent. The average yield amounts to 3.78%.

Here is the sheet of the best yielding, higher capitalized ex-dividend stocks: 

Company	Ticker	Mcap	P/E	P/B	P/S	Yield
Medley Capital Corporation	MCC	429.61M	10.78	1.18	7.95	9.61%
Ambassadors Group Inc.	EPAX	79.64M	22.60	0.91	1.36	5.31%
Six Flags Entertainment Corporation	SIX	3.62B	41.90	4.13	3.40	5.30%
Sun Life Financial Inc.	SLF	16.96B	28.86	1.03	0.85	5.13%
Great Plains Energy	GXP	3.38B	16.93	0.99	1.46	3.95%
Sonoco Products Co.	SON	3.18B	17.75	2.09	0.67	3.80%
Snyder's-Lance, Inc.	LNCE	1.75B	29.92	2.02	1.08	2.52%
Steris Corp.	STE	2.25B	13.85	2.45	1.54	1.97%
Dun & Bradstreet Corp.	DNB	3.62B	12.54	-	2.18	1.87%
Tower Financial Corporation	TOFC	60.27M	10.47	0.92	2.32	1.78%
Mesa Laboratories Inc.	MLAB	179.85M	21.90	3.58	4.12	1.05%
Griffon Corporation	GFF	686.78M	43.15	1.04	0.37	0.89%

100 Best Small Cap Stocks To Place Your Money

Small cap stocks with a strong growth and best dividends to buy, originally published at “long-term-investments.blogspot.com”. Everybody loves growth. If you own an investment and it starts to grow by double-digit rates over a few years, when the stock price explode and you feel like a bird in heaven. I felt a few times like this. But it is also necessary that you sell partly your position over the time. I personally reduce my stocks positions when they have doubled or more. Certainly you can’t get very rich with this rule but you hedge your stock gains and believe me by selling stocks with gains, nobody become poor.

I recently viewed a nice list at Forbes. The list was a research result of the 100 best small cap growth stocks in America. Stocks from the table are public and tradeable in America. They all have a total sales volume below the USD 1 billion mark and fantastic years of recent growth. As you can see at the list, the GDP growth is America is still weak but out there are still investment opportunities to discover.

I discovered the ten best dividend stocks from the small cap growth picks. I needed to screen more than 50 companies in order to find ten stocks with positive dividend payments. Most of the small cap growth stocks don’t pay dividends. But the debt situation is very comfortable. Most of them are free of debt and have bigger cash amounts to their balance sheets in order to finance future growth. The average stock grew in sales by 19 percent yearly. Earnings followd by 31 percent growth yearly and the average return on equity amounted to 20 percent. See the full list of the 100 best small cap growth stocks at the end of this post.

12 Healthcare Dividend Stocks With Gaining Earnings Momentum

Healthcare Dividend Stocks With Accelerated Growth Researched By Dividend Yield - Stock, Capital, Investment. Growth stocks are wonderful especially if they are at the beginning of their growth path. Growth normally creates shareholder value and if the company doesn’t need much money to finance the growth, you can benefit already within the early stage.

I screened the healthcare sector by stocks with a recent earnings growth of more than ten percent (past five years). In order to catch up only those stocks with a gaining earnings growth, I observed only stocks with a quarter over quarter sales and earnings per share growth of more than 10 percent. Exactly twelve companies fulfilled these criteria. All of them are recommended to buy.

10 High Margin Healthcare Dividend Shares

Perfect Healthcare Dividend Stocks With High Margins by Dividend Yield - Stock, Capital, Investment. I screened stocks from the healthcare sector with a positive dividend yield as well as an operating margin of more than 25 percent. Most of the stocks come from the medical instruments and supplies industry but the highest margin stocks are from the drug, biotechnology and diagnostic industry. 5 stocks from the screening results have a yield of more than 3 percent.

Here are the 3 top dividend stocks sorted by yield:

(Subscribe my Blog via RSS Feed or E-Mail. Alternative, you can follow me on Facebook or Twitter)

PDL BioPharma (NASDAQ: PDLI) has a market capitalization of $866.97 million. The company employs 8 people, generates revenues of $344.98 million and has a net income of $91.87 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $193.52 million. Because of these figures, the EBITDA margin is 56.10 percent (operating margin 56.07 percent and the net profit margin finally 26.63 percent).


The total debt representing 178.77 percent of the company’s assets. Twelve trailing months earnings per share reached a value of $0.74. Last fiscal year, the company paid $1.00 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 8.43, Price/Sales 2.51 and Price/Book ratio is not calculable. Dividend Yield: 9.68 percent. The beta ratio is 0.54.

Long-Term Stock History Chart Of PDL BioPharma Inc. (Click to enlarge)

Long-Term History of Dividends from PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)

Long-Term Dividend Yield History of PDL BioPharma Inc. (NASDAQ: PDLI) (Click to enlarge)

AstraZeneca (NYSE: AZN) has a market capitalization of $61.13 billion. The company employs 61,100 people, generates revenues of $33,269.00 million and has a net income of $8,081.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $13,380.00 million. Because of these figures, the EBITDA margin is 40.22 percent (operating margin 34.55 percent and the net profit margin finally 24.29 percent).


The total debt representing 16.43 percent of the company’s assets and the total debt in relation to the equity amounts to 39.73 percent. Due to the financial situation, a return on equity of 36.71 percent was realized. Twelve trailing months earnings per share reached a value of $7.29. Last fiscal year, the company paid $2.55 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 6.35, Price/Sales 1.78 and Price/Book ratio 2.81. Dividend Yield: 5.83 percent. The beta ratio is 0.62.

Long-Term Stock History Chart Of AstraZeneca plc (ADR) (Click to enlarge)

Long-Term History of Dividends from AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)

Long-Term Dividend Yield History of AstraZeneca plc (ADR) (NYSE: AZN) (Click to enlarge)

Meridian Bioscience (NASDAQ: VIVO) has a market capitalization of $777.02 million. The company employs 525 people, generates revenues of $159.72 million and has a net income of $26.83 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $45.73 million. Because of these figures, the EBITDA margin is 28.63 percent (operating margin 25.06 percent and the net profit margin finally 16.80 percent).


The total debt representing 0.00 percent of the company’s assets and the total debt in relation to the equity amounts to 0.00 percent. Due to the financial situation, a return on equity of 19.45 percent was realized. Twelve trailing months earnings per share reached a value of $0.65. Last fiscal year, the company paid $0.76 in form of dividends to shareholders.


Here are the price ratios of the company: The P/E ratio is 29.03, Price/Sales 4.86 and Price/Book ratio 5.61. Dividend Yield: 4.03 percent. The beta ratio is 0.80.

Long-Term Stock History Chart Of Meridian Bioscience, Inc. (Click to enlarge)

Long-Term History of Dividends from Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Long-Term Dividend Yield History of Meridian Bioscience, Inc. (NASDAQ: VIVO) (Click to enlarge)

Here is the full table with some fundamentals (TTM):

10 High Margin Healthcare Dividend Shares (Click to enlarge)

Take a closer look at the full table. The average price to earnings ratio (P/E ratio) amounts to 17.62 while the forward price to earnings ratio is 14.23. The dividend yield has a value of 3.46 percent. Price to book ratio is 4.28 and price to sales ratio 4.17. The operating margin amounts to 37.47 percent.

Related stock ticker symbols:

PDLI, AZN, VIVO, BMY, UTMD, AMGN, TECH, NVO, MLAB, ATRI

Selected Articles:

· Best Healthcare Stock Picks For 2012

· 12 Healthcare Dividend Stocks With Best Future EPS Growth

· 14 Healthcare Dividend Stocks With Biggest Institutional Buys

· 8 Healthcare Dividend Stocks Close to 52-Week Low

* I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I receive no compensation to write about any specific stock, sector or theme.